Interstitial Lung Disease clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 40 years and up

    Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

    Sacramento, California and other locations